logo
  • Home
  • News
Menu

Vaccine Stocks Nab Booster Shot OK, But Their Run Could Be Short-Lived

Home / Stock Analysis / Vaccine Stocks Nab Booster Shot OK, But Their Run Could Be Short-Lived
Article feature image

Vaccine Stocks Nab Booster Shot OK, But Their Run Could Be Short-Lived

13 Aug Stock Analysis

Vaccine stocks Moderna (MRNA), BioNTech (BNTX) and Pfizer (PFE) initially popped Friday after the Food and Drug Administration authorized a third dose of their Covid shots for some immunocompromised people.
XNow, organ transplant recipients and those with…

Click here to view the original article.

Tags:
Global, Investor's Business Daily
Facebook Google+ Twitter Pinterest
  Previous
Next  

Related Posts

og-image-news-20240226.png
+

Stock Analysis | Charles River Laboratories International Outlook

01 Sep Stock Analysis
1585186892307.jpeg
+

Wanjia Group Holdings Limited (HKG:401) Stock Catapults 45% Though Its Price And Business Still Lag The Industry

01 Sep Stock Analysis

recent post

  • og-image-news-20240226.png

    Stock Analysis | Charles River Laboratories

    Sep 01 2025
  • og-image-news-20240226.png

    Geopolitical Realignment and the Rise of

    Sep 01 2025
  • 1585186892307.jpeg

    Wanjia Group Holdings Limited (HKG:401) Stock

    Sep 01 2025
  • og-image-news-20240226.png

    The Meme-to-Earn Revolution in Crypto and

    Sep 01 2025
  • og-image-news-20240226.png

    Why Industronics Berhad’s Earnings Deterioration Signals

    Sep 01 2025

Categories

  • Business
  • Crypto News
  • Investing Strategy
  • People
  • Stock Analysis

©2019.  All Rights Reserved.